Secondary (preplanned) analysis of the PADDI trial in 1130 people with diabetes: intraoperative dexamethasone 8 mg raised median peak 24-h glucose to 12.5 vs 10.3 mM with placebo (difference 1.86 mM), without more surgical-site infection (11.1% vs 14.4%).
RCTn = 1,130
Bach et al. The effect of intraoperative dexamethasone on glycaemic responses in people with diabetes mellitus: a preplanned analysis of the Perioperative ADministration of Dexamethasone and Infection trial